Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD

Recognizing the clinical heterogeneity of COPD suggests a specific therapeutic approach directed by the so-called clinical phenotypes of the disease. The Spanish COPD Guidelines (GesEPOC) is an initiative of SEPAR, which, together with the scientific societies involved in COPD patient care, and the...

Descripción completa

Detalles Bibliográficos
Autores: Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Riesco JA, Trigueros JA, Piñera P, Simón A, López-Campos JL, Soriano JB, Ancochea J
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2012
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p7141
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/7141
Access Level:acceso abierto
Palabra clave:COPD
Treatment
Guidelines
id ES_7a1884be4b59deb1e8ff17ff0aa9f23d
oai_identifier_str oai:fisabio.fundanetsuite.com:p7141
network_acronym_str ES
network_name_str España
repository_id_str
spelling Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPDMiravitlles MSoler-Cataluña JJCalle MMolina JAlmagro PQuintano JARiesco JATrigueros JAPiñera PSimón ALópez-Campos JLSoriano JBAncochea JCOPDTreatmentGuidelinesRecognizing the clinical heterogeneity of COPD suggests a specific therapeutic approach directed by the so-called clinical phenotypes of the disease. The Spanish COPD Guidelines (GesEPOC) is an initiative of SEPAR, which, together with the scientific societies involved in COPD patient care, and the Spanish Patient Forum, has developed these new clinical practice guidelines. This present article describes the severity classification and the pharmacological treatment of stable COPD. GesEPOC identifies four clinical phenotypes with differential treatment: non-exacerbator, mixed COPD-asthma, exacerbator with emphysema and exacerbator with chronic bronchitis. Pharmacological treatment of COPD is based on bronchodilation in addition to other drugs depending on the clinical phenotype and severity. Severity is established by the BODE/BODEx multidimensional scales. Severity can also be approximated by assessing airflow obstruction, dyspnea, level of physical activity and history of exacerbations. GesEPOC is a new, more individualized approach to COPD treatment according to the clinical characteristics of the patients. (C) 2012 Elsevier Espana, S.L. All rights reserved.EDICIONES DOYMA S A2012info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/7141Atencion PrimariaISSN: 02126567ISSNe: 15781275reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Españolinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p71412026-06-11T12:45:17Z
dc.title.none.fl_str_mv Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD
title Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD
spellingShingle Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD
Miravitlles M
COPD
Treatment
Guidelines
title_short Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD
title_full Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD
title_fullStr Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD
title_full_unstemmed Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD
title_sort Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD
dc.creator.none.fl_str_mv Miravitlles M
Soler-Cataluña JJ
Calle M
Molina J
Almagro P
Quintano JA
Riesco JA
Trigueros JA
Piñera P
Simón A
López-Campos JL
Soriano JB
Ancochea J
author Miravitlles M
author_facet Miravitlles M
Soler-Cataluña JJ
Calle M
Molina J
Almagro P
Quintano JA
Riesco JA
Trigueros JA
Piñera P
Simón A
López-Campos JL
Soriano JB
Ancochea J
author_role author
author2 Soler-Cataluña JJ
Calle M
Molina J
Almagro P
Quintano JA
Riesco JA
Trigueros JA
Piñera P
Simón A
López-Campos JL
Soriano JB
Ancochea J
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv COPD
Treatment
Guidelines
topic COPD
Treatment
Guidelines
description Recognizing the clinical heterogeneity of COPD suggests a specific therapeutic approach directed by the so-called clinical phenotypes of the disease. The Spanish COPD Guidelines (GesEPOC) is an initiative of SEPAR, which, together with the scientific societies involved in COPD patient care, and the Spanish Patient Forum, has developed these new clinical practice guidelines. This present article describes the severity classification and the pharmacological treatment of stable COPD. GesEPOC identifies four clinical phenotypes with differential treatment: non-exacerbator, mixed COPD-asthma, exacerbator with emphysema and exacerbator with chronic bronchitis. Pharmacological treatment of COPD is based on bronchodilation in addition to other drugs depending on the clinical phenotype and severity. Severity is established by the BODE/BODEx multidimensional scales. Severity can also be approximated by assessing airflow obstruction, dyspnea, level of physical activity and history of exacerbations. GesEPOC is a new, more individualized approach to COPD treatment according to the clinical characteristics of the patients. (C) 2012 Elsevier Espana, S.L. All rights reserved.
publishDate 2012
dc.date.none.fl_str_mv 2012
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/7141
url https://fisabio.portalinvestigacion.com/publicaciones/7141
dc.language.none.fl_str_mv Español
language_invalid_str_mv Español
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv EDICIONES DOYMA S A
publisher.none.fl_str_mv EDICIONES DOYMA S A
dc.source.none.fl_str_mv Atencion Primaria
ISSN: 02126567
ISSNe: 15781275
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411412228440064
score 15.811543

Similares en LA Referencia